Sittinon Tang

Prolactin Induced Protein (PIP) is a potential biomarker for early stage and malignant breast cancer.

A. Goy, Takemi Tanaka, A. Pecora, 2018, Breast.

Nemvaleukin alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancer

Kwok-Kin Wong, V. Velcheti, Hsin-Yi Huang, 2022, Journal for ImmunoTherapy of Cancer.

KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition.

H. Ji, A. Bass, A. Moreira, 2022, Cancer cell.

Targeting HER2 Exon 20 Insertion–Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib

Kwok-Kin Wong, Haiquan Chen, C. Peng, 2021, Cancer Research.

Targeting the Atf7ip–Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity

D. Schadendorf, B. Ueberheide, Ting Chen, 2021, Cancer Immunology Research.

Loss of TSC1/TSC2 sensitizes immune checkpoint blockade in non–small cell lung cancer

G. Freeman, Kwok-Kin Wong, Haiquan Chen, 2022, Science advances.

Title : Targeting HER 2 Exon 20 Insertion-Mutant Lung Adenocarcinoma with a Novel 2 Tyrosine Kinase Inhibitor

Kwok-Kin Wong, Haiquan Chen, V. Rivera, 2021 .

Histone deacetylase 6 inhibition exploits selective metabolic vulnerabilities in LKB1 mutant, KRAS driven non-small cell lung cancer.

Ting Chen, M. V. Vander Heiden, N. Bardeesy, 2023, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.